🌍·15h agoRegulatory
Ανάκληση της παρτίδας H0444C του φαρμακευτικού προϊόντος NILOTINIB/TEVA caps 200mg/cap BT x 112
Publisher
E
EOF Greece
Greece
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- EOF Greece
- Region
- Greece
- Scope
- Regulatory
- Published
- June 17, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on eof.gr
Leave the platform to read the original full article on the publisher site.
Source: EOF Greece
Scope: Regulatory
Related coverage
More related coverage
MHRA UK/15h ago
Guidance: COVID-19 test validation approved products
IFPMA Global/20h ago
Pharmaceutical industry mobilizes to support response to the Ebola Bundibugyo virus disease outbreak and calls for a system that enables rapid response and sustained R&D investment
ACRP Association/1d ago
Leveraging Artificial Intelligence for Clinical Trial Recruitment and Retention
ACRP Association/1d ago